Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (06): 55-60    DOI: 10.13523/j.cb.20140608
    
The Analysis and Preparation of the Stress Associated Phosphorylation Antibodies Specific for the T103 Site of Tudor-SN Protein
GAO Xing-jie1, ZHANG Yi2, SU Chao1, FU Xue1, SHI Xue-bin3, YIN Jie1, HE Jin-yan3, WANG Xin-ting3, YAO Zhi3, YANG Jie1,3
1. Basic Medical College and Research Center, Tianjin Medical University, Tianjin 300070, China;
2. College of Pharmacy Tianjin Medical University, Tianjin 300070, China;
3. School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
Download: HTML   PDF(1529KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To prepare and analyze the rabbit polyclonal stress associated phosphorylation antibodies specific for the T103 (Thr103) site of Tudor-SN protein. Methods: The phosphorylated T103 (pT103) site-containing polypeptide was synthesized; Antiserums were collected from the New Zealand white rabbits immunized with the polypeptide four times and purified through AKTA protein purification system. The Western blotting analysis,immunofluorescence experiment and In-cell Western assay were performed using the purified anti-pT103 antibodies. Results: (1) The phosphorylated peptide "TIENKpTPQGRC" was synthesized and about 75 ml rabbit antiserums were collected (2.08 mg/ml); (2) The phosphorylation signal was detected and increased under oxidative stress conditions in Western blotting analysis; the granule signal was also observed in the cytoplasm of HeLa cells and co-localized with the endogenous Tudor-SN-labeled stress granule during stress. (3) The phosphorylation level of Tudor-SN at T103 site fluctuates during the oxidative stress and after the removal of stress. Conclusion: The rabbit polyclonal anti-pT103 antibodies specific for the T103 site of Tudor-SN were prepared successfully. It will help to study the role of Tudor-SN phosphorylation modification in cellular stress responses.



Key wordsTudor-SN      Phosphorylation      Antibodies      Stress granules     
Received: 08 April 2014      Published: 25 June 2014
ZTFLH:  Q71  
Cite this article:

GAO Xing-jie, ZHANG Yi, SU Chao, FU Xue, SHI Xue-bin, YIN Jie, HE Jin-yan, WANG Xin-ting, YAO Zhi, YANG Jie. The Analysis and Preparation of the Stress Associated Phosphorylation Antibodies Specific for the T103 Site of Tudor-SN Protein. China Biotechnology, 2014, 34(06): 55-60.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140608     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I06/55


[1] Valineva T, Yang J, Palovuor I R, et al. The transcriptional co-activator protein p100 recruits histone acetyl transferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J Biol Chem, 2005, 280(15): 14989-14996.

[2] Gao X, Zhao X, Zhu Y, et al. Tudor staphylococcal nuclease (Tudor-SN) articipates in small ribonucleoprotein (snRNP) assembly viainteracting with symmetrically dimethylated Sm proteins. J Biol Chem, 2012, 287(22): 18130-18141.

[3] Sundstrm J F, Vaculova A, Smertenko A P, et al. Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome. Nat Cell Biol, 2009, 11(11): 1347-1354.

[4] Gao X, Ge L, Shao J, et al. Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions. FEBS Lett, 2010, 584(16):3525-3532.

[5] Buchan J R, Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol Cell, 2009, 36(6): 932-941.

[6] Thomas M G, Loschi M, Desbats M A, et al. RNA granules: the good, the bad and the ugly. Cell Signal, 2011, 23(2): 324-334.

[7] Erickson S L, Lykke-Andersen J. Cytoplasmic mRNP granules at a glance. J Cell Sci, 2011, 124(Pt3): 293-297.

[8] Maroney P A, Yu Y, Fisher J, et al. Evidence that microRNAs are associated with translating messenger RNAs in human cells. Nat Struct Mol Biol, 2006, 13(12): 1102-1107.

[9] Ohn T, Anderson P. The role of posttranslational modifications in the assembly of stress granules. Wiley Interdiscip Rev RNA, 2010, 1(3): 486-493.

[10] Mokas S, Mills J R, Garreau C, et al. Uncoupling stress granule assembly and translation initiation inhibition. Mol Biol Cell, 2009, 20(11): 2673-2683.

[11] Tourriere H, Chebli K, Zekri L, et al. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol, 2003, 160(6): 823-831.

[12] Weissbach R, Scadden A D. Tudor-SN and ADAR1 are components of cytoplasmic stress granules. RNA, 2012, 18(3): 462-471.

[13] Zhu L, Tatsuke T, Mon H, et al. Characterization of Tudor-sn-containing granules in the silkworm, Bombyx mori. Insect Biochem Mol Biol, 2013, 43(8): 664-674.

[14] Spector D L. SnapShot: Cellular Bodies Cell, 2006, 127(5):1071.

[1] SHI Rui,YAN Jing-hua. Research Progress of Neutralizing Antibody Drugs against SARS-CoV-2[J]. China Biotechnology, 2021, 41(6): 129-135.
[2] ZHANG Sai,XIANG Le,LI Lin-hai,LI Hui-jun,WANG Gang,QIAN Chun-gen. Development and Performance Evaluation of A Rapid IgM-IgG Combined Antibody Test for 2019 Novel Coronavirus Infection[J]. China Biotechnology, 2020, 40(8): 1-9.
[3] Qian GAO,Hong JIANG,Mao YE,Wen-juan GUO. Current Status and Trend of R&D of Monoclonal Antibodies[J]. China Biotechnology, 2019, 39(3): 111-119.
[4] Jing-wen XU,Xue-mei ZHANG,Zhong-xiang WU,Wen-bing ZHU,Xi JIANG,Wei GONG,Li-wei YAN,Jie SONG,Hui LI,Shao-zhong DONG. Preparation and Identification of Monoclonal Antibodies Against Tree Shrews CD3ε[J]. China Biotechnology, 2018, 38(4): 54-62.
[5] Li DU,Xiao-zhi LIU,Jian GAO,Zhi-ming WANG. Research Progress on Immunogenicity Evaluation of Antibodies[J]. China Biotechnology, 2018, 38(2): 89-94.
[6] LI Min, WU Ri-wei. The Market Overview of Monoclonal Antibodies in Both Domestic and Abroad[J]. China Biotechnology, 2017, 37(3): 106-114.
[7] MENG Guo-ji, DENG Yi-xi, LI Le, LUO Hao-hui, YU Yu-gen. Promotion in ProteinA Chromatography of WLB303 Monoclonal Antibody by Using Dual Flowrate to Load Sample[J]. China Biotechnology, 2016, 36(6): 65-75.
[8] ZHOU Li-jun, LIU Wen-juan, QI Yong-hao, LI Miao. SOCS3 Negatively Regulates AKT through JNK and STAT3 Signal Pathways[J]. China Biotechnology, 2015, 35(9): 50-56.
[9] MAO Kai-yun, YANG Lu, WANG Heng-zhe, CHEN Da-ming. Market Status and Development Trend of Biotech Drugs[J]. China Biotechnology, 2015, 35(1): 111-119.
[10] LI Pu, SHI Jing, CHENG Fen, LIANG Qin-dong, KUANG Wen-bin, WANG Qin, DONG Jin-yu, TU Zhi-guang. Preparation, Characterization and Application of Monoclonal Antibodies Against Human Y box-binding Protein 1[J]. China Biotechnology, 2012, 32(6): 13-19.
[11] LIU Qi-gang, DAI Yun-jian, ZHANG Yong-xia, WANG Bao-cheng, WANG Ming-rong. Efficient Soluble Expression of Anti-IgE scFv in E.coli and Optimization of Expression Conditions[J]. China Biotechnology, 2012, 32(11): 23-28.
[12] LIU Qi-gang, DAI Yun-jian, ZHANG Yong-xia, WANG Bao-cheng, WANG Ming-rong. Efficient Soluble Expression of Anti-IgE scFv in E.coli and Optimization of Expression Conditions[J]. China Biotechnology, 2012, 32(11): 23-28.
[13] YANG Ya-qiong, LI Zong-hai. Recent Development of Molecular Targeted Cancer Drugs Targeted EGFR[J]. China Biotechnology, 2012, 32(05): 91-96.
[14] ZHAN Sheng, YIN Xing-feng, LI Hui, LI Nan, YANG Xiao-yan, SUN Xue-song. Effect of the Incubation Time in the Enrichment of the Phosphopeptides with Titanium Dioxide[J]. China Biotechnology, 2012, 32(03): 59-62.
[15] TIAN Xue-jun, YANG Yi, LIU Jing, CHEN Kan. Effect of Phosphorylation by Akt on Miz1's Ubiquitination[J]. China Biotechnology, 2011, 31(8): 7-11.